Plasmapheresis or intravenous immunoglobulin for myasthenia gravis crisis in King Chulalongkorn Memorial Hospital.

Simple item page
dc.contributor.authorPittayanon, Rapaten_US
dc.contributor.authorTreeprasertsuk, Sombaten_US
dc.contributor.authorPhanthumchinda, Kammanten_US
dc.date.accessioned2009-05-27T18:54:27Z
dc.date.available2009-05-27T18:54:27Z
dc.date.issued2009-04-21en_US
dc.descriptionChotmaihet Thangphaet.en_US
dc.description.abstractBACKGROUND: Myasthenia gravis (MG) crisis is a life-threatening and unpredictable complication of MG Prognosis of MG crisis has dramatically improved due to modern immunomodulation. However the choice of plasmapheresis or intravenous immunoglobulin (IVIG) is still a controversial issue. OBJECTIVE: Evaluate the efficacy and outcomes of MG crisis treatment with plasmapheresis or IVIG in King Chulalongkorn Memorial Hospital (KCMH) during the past 5 years. MATERIAL AND METHOD: Episodes of MG crisis with respiratory failure were recruited retrospectively from database of KCMH between 2001 and 2006. RESULTS: Thirty-three episodes of MG crisis with respiratory failure from 26 patients (9 males and 17 females) were documented. Plasmapheresis and IVIG were prescribed in 21 and 9 episodes of MG crisis, respectively. There was no statistical significant difference in baseline characteristics between both groups. The mean duration of intubation in plasmapheresis group was 12 +/- 11.1 days and in IVIG group was 10.3 +/- 4.6 days. The mean length of hospital stay (LOS) in plasmapheresis and IVIG were 30.7 +/- 29.6 days and 25.4 +/- 16.2 days, respectively. Hospital acquired pneumonia (HAP) occurred in four episodes (18.2%) in plasmapheresis and 1 episode (11.1%) in IVIG There was no statistical difference in the outcome of both treatment groups. All patients in both groups were well upon discharge. CONCLUSION: MG crisis with respiratory failure was safely managed with either plasmapheresis or IVIG in KCMH. The present study cannot demonstrate any differences in the efficacy of plasmapheresis or IVIG. This may be due to inadequate sample size thus more patients should be recruited for further study.en_US
dc.description.affiliationDepartment of Medicine, Faculty of Medicine, King Chulalongkorn Memorial Hospital, Chulalongkorn University, Bangkok, Thailand. Rapat125@gmail.comen_US
dc.identifier.citationPittayanon R, Treeprasertsuk S, Phanthumchinda K. Plasmapheresis or intravenous immunoglobulin for myasthenia gravis crisis in King Chulalongkorn Memorial Hospital. Journal of the Medical Association of Thailand. 2009 Apr; 92(4): 478-82en_US
dc.identifier.urihttps://imsear.searo.who.int/handle/123456789/40088
dc.language.isoengen_US
dc.source.urihttps://www.mat.or.th/journal/all.phpen_US
dc.titlePlasmapheresis or intravenous immunoglobulin for myasthenia gravis crisis in King Chulalongkorn Memorial Hospital.en_US
dc.typeJournal Articleen_US
Files
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.79 KB
Format:
Plain Text
Description:
Download
Collections
Journal of the Medical Association of Thailand